论文部分内容阅读
目的:系统评价不同输注方式对帕拉西林-他唑巴坦钠临床疗效的影响。方法:在Pub Med,Web of Science,Pro Quest,Embase,Science Direct,Cochrane上检索所有2015年1月1日前所有相关文献,采用Revman 5.3软件进行分析。结果:共纳入2篇RCT和10篇观察性研究文献,结果显示延长给药组或连续给药组相对于传统给药方法,能降低临床死亡率[OR 0.68,CI(0.53,0.88),P=0.003],但临床有效率差异无统计学意义[OR 0.84,CI(0.83,2.50),P=0.20]。结论:帕拉西林-他唑巴坦钠采用延长或连续输注的方式可以降低死亡率,临床值得推荐。
Objective: To systematically evaluate the effect of different infusion methods on the clinical efficacy of paracetamol-tazobactam sodium. METHODS: All relevant literature was retrieved on Pub Med, Web of Science, Pro Quest, Embase, Science Direct, and Cochrane for all studies by January 1, 2015 and analyzed using Revman 5.3 software. Results: A total of 2 RCTs and 10 observational studies were included. The results showed that the prolonged or continuous administration group decreased the clinical mortality rate compared with the traditional administration methods [OR 0.68, CI (0.53, 0.88), P = 0.003], but there was no significant difference in clinical efficacy [OR 0.84, CI (0.83, 2.50), P = 0.20]. Conclusions: Prophylaxis of paracillin-tazobactam sodium by prolonged or continuous infusion reduces mortality.